Top 5 Heal Care Stocks For 2014

DELAFIELD, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track big changes in volume activity. Often when above-average volume moves into an equity, it precedes a large spike in volatility.

>>5 Stocks Insiders Love Right Now

Major moves in volume can signal unusual activity, such as insider buying or selling -- or buying or selling by "superinvestors."

Unusual volume can also be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst. These types of traders like to get in well before a large spike, so it's always a smart move to monitor unusual volume. That said, remember to combine trend and price action with unusual volume. Put them all together to help you decipher the next big trend for any stock.

>>5 Stocks Set to Soar on Bullish Earnings

With that in mind, let's take a look at several stocks rising on unusual volume today.

10 Best Quality Stocks To Watch Right Now: Hemp Inc (HEMP)

Hemp, Inc. is a United States-based company that focuses primarily on the industrial hemp (over 25,000 products made from hemp that the hemp plant offers). Hemp, Inc.'s primary focus is on industrial hemp and the myriad of uses (over 25,000 products made from hemp that the hemp plant offers) in creating a new, clean green American agricultural and industrial revolution.

The Industrial Hemp and Medical Marijuana Consulting Company (IHMMCC) is a wholly owned subsidiary of the Company that pulls industry information from a vast network of specialists. On September 25, 2014, its wholly owned subsidiary, Industrial Hemp Manufacturing, LLC (IHM), purchased and secured its permanent facility for the Temafa decortication line of equipment located in Spring Hope, NC, the facility encompasses two buildings totaling nearly 70,000 square feet that spans almost seven acres.

Advisors' Opinion:

• [By James E. Brumley]

  A week and a half ago when I suggested Latteno Food Corp. (OTCMKTS:LATF) was an effective way of getting into the medical marijuana craze for anyone who missed the big runups (the first or the second time) from names like Medical Marijuana Inc. (OTCMKTS:MJNA) or Hemp, Inc. (OTCMKTS:HEMP), not many people agreed with my assessment. That's the nice way of saying I received some "colorful counter-opinions" to my bullishness on LATF. Indeed, some readers were downright enraged I would dare compare the company to stocks like MJNA or HEMP, citing reasons ranging from the possibility that it's a complete scam to the possibility that the capital structure as amazingly unfair to current shareholders.

• [By James E. Brumley]

  Wow. That didn't take long. It was only two days ago that marijuana stocks like Growlife Inc. (OTCBB:PHOT), Medical Marijuana Inc. (OTCMKTS:MJNA), Cannabis Science Inc. (OTCMKTS:CBIS), Medbox Inc. (OTCMKTS:MDBX), and Hemp, Inc. (OTCMKTS:HEMP) were all the rage, flying high on the heels of a new year... a new year in which marijuana was legalized (for one reason or another) in two more states. HEMP was up as much as 700% in less than three weeks at one point. MDBX gained 300% at the beginning of the year, when recreational marijuana began to be legally sold in Colorado. CBIS jumped 400% off of its December low. MJNA nearly doubled on the advent of new marijuana venues. PHOT soared more than 130% since the end of last year on the legalization of marijuana. It was, truthfully, some of the fastest big money that traders have ever made in the market.

• [By Dan Burrows]

  Just look at Hemp Inc. (HEMP). HEMP stock rallied as much as 60% Tuesday on anticipation of the Senate’s approval of the�farm bill that would effectively legalize the cultivation of hemp. And hemp isn’t something you even smoke. This close cousin of marijuana cannabis can be refined into a wide-range of goods, including hemp oil, rope, cloth, paper and fuel. But it doesn’t have medical or recreational uses like marijuana does.

Top 5 Heal Care Stocks For 2014: Enanta Pharmaceuticals Inc (ENTA)

Enanta Pharmaceuticals, Inc., incorporated on July 25, 1995, is a research and development-focused biotechnology company. The Company uses its chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field. The Company is discovering and developing novel inhibitors designed for use against the hepatitis C virus (HCV). These inhibitors include members of the direct acting antiviral (DAA) inhibitor classes-protease (partnered with AbbVie, the former research-based pharmaceutical business of Abbott Laboratories), NS5A (partnered with Novartis) and nucleotide polymerase, as well as a host targeted antiviral (HTA) inhibitor class targeted against cyclophilin. ABT-450, discovered through its collaboration with AbbVie, is a protease inhibitor that has demonstrated in vitro potency against known resistant HCV mutants.

In Phase I studies, ABT-450 co-administered with ritonavir, a commonly used boosting agent to increase the blood concentrations of many protease inhibitors, was shown to be safe and well tolerated. Co-administration of ABT-450 with ritonavir, which it refers to together as ABT-450/r, has enabled once-daily dosing of ABT-450. Phase II studies have demonstrated the efficacy of ABT-450/r in patients with chronic HCV, and other interferon-free Phase II studies of ABT-450-containing regimens continue. AbbVie is developing a next-generation protease inhibitor discovered within the Enanta-AbbVie collaboration. EDP-239 is the NS5A inhibitor discovered by the Company. The Company also has a program to develop nucleotide inhibitors to HCV NS5B polymerase, which is another DAA mechanism considered to have a barrier to resistance. The Company�� Bicyclolide antibiotic product candidate is EDP-788, which it is developing for use as an intravenous drug in the hospital setting and for oral dosing in the home setting. EDP-788 is a prodrug, which means that it is inactive until it is converted in the body into an active compound. EDP-788 is! a water-soluble molecule which, when administered in preclinical models, is cleanly and rapidly converted into the active compound.

Advisors' Opinion:

• [By Sean Williams]

  The next big thing in treating hepatitis-C
  The other currently experimental therapy very likely to make it onto the FDA's desk before the midpoint of 2014 is AbbVie's (NYSE: ABBV  ) direct-acting antiviral combo drug. In similar fashion to Sovaldi, this DAA-combo therapy, which includes ABT-450 from Enanta Pharmaceuticals (NASDAQ: ENTA  ) , is running six confirmatory late-stage trials on various genotypes. There are, however, two primary differences between AbbVie's DAA-combo therapy and Sovaldi.

• [By George Budwell]

  Normally, such strong efficacy results would be hailed as a major achievement. However, these results are actually less impressive than those by competing drug's developed by AbbVie (NYSE: ABBV  ) , Enanta Pharmaceuticals (NASDAQ: ENTA  ) and Gilead. Bristol-Myers' therapy also has a treatment duration double that of Gilead's drug Sovaldi for genotype 1 patients. So, while these results are impressive in their own right, the therapy's commercial prospects may be limited due to the presence of superior competitors in the market.�

Top 5 Heal Care Stocks For 2014: Central Garden & Pet Company (CENTA)

Central Garden & Pet Company produces and sells various products for the pet, and lawn and garden supplies markets in the United States. The company operates in two segments, Pet, and Lawn and Garden. The Pet segment supplies products for dogs and cats comprising edible bones, edible and non-edible chews, dog and cat food and treats, toys, pet carriers, grooming supplies, and other accessories; and food, cages and habitats, toys, chews, and related accessories for birds, small animals, and specialty pets. It also offers animal and household health, and insect control products; aquariums, furniture and lighting fixtures, pumps, filters, water conditioners, food and supplements, and information and knowledge resources for fish, reptiles, and other aquarium-based pets; and products for horses and livestock. This segment sells its products to independent pet distributors, retail chains, grocery stores, mass merchants, and bookstores under various brand names, which include Ada ms, Aqueon, Avoderm, BioSpot, Farnam, Four Paws, Kaytee, Nylabone, Pinnacle, TFH, Zilla, Altosid, Comfort Zone, Coralife, Interpet, Kent Marine, Oceanic Systems, Pet Select, Pre-Strike, Super Pet, and Zodiac. The Lawn and Garden segment provides grass seeds; wild bird feed, bird feeders, bird houses, and other birding accessories; weed, grass, ant and other herbicide, insecticide, and pesticide products; and decorative outdoor lifestyle and lighting products, such as comprising potteries, trellises and other wood products, and holiday lighting products. This segment sells its products to retail chains, independent garden distributors, grocery stores, nurseries, and garden supply retailers under the AMDRO, GKI/Bethlehem Lighting, Ironite, Pennington, Sevin, Grant�s, Lilly Miller, Matthews Four Seasons, New England Pottery, Norcal Pottery, Over-N-Out, Smart Seed, and The Rebels brand names. The Company was founded in 1955 and is based in Walnut Creek, California.

Advisors' Opinion:

• [By Sean Williams]

  Green paw
  The month of May has been one to forget for shareholders of Central Garden & Pet (NASDAQ: CENT  ) (NASDAQ: CENTA  ) . The maker of pet products as well as seeds and herbicides for lawn care tumbled after it missed Wall Street's earnings estimates for a second straight quarter. The biggest downside pressure came from its lawn care segment, which saw expenses rise as fertilizer margins fell. However, now could be the time to consider jumping on board this interesting pet/lawn care hybrid company, as it has the potential to unlock shareholder value in a number of ways.

Top 5 Heal Care Stocks For 2014: Dragonwave Inc(DRWI)

Dragonwave Inc. provides wireless Ethernet equipment for emerging Internet protocol networks worldwide. It designs, develops, markets, and sells carrier-grade microwave radio frequency networking equipment that wirelessly transmit broadband voice, video, and other data between two points. The company?s products have application in the backhaul function in a wireless communications network, as well as in point-to-point transport in private networks, including municipal and enterprise applications. It markets its wireless carrier-Ethernet links under the Horizon trade name. The company also offers service delivery unit solution products based on pseudowire technology. It markets its products to communications service providers comprising cellular service providers and broadband wireless access service providers; wireless extension of fixed-line networks to directly connect high-bandwidth end-customers to the core network; and private networks of large multi-site organizatio ns directly, as well as through distributors and regional value-added resellers. The company was founded in 2000 and is headquartered in Ottawa, Canada.

Advisors' Opinion:

• [By Monica Gerson]

  DragonWave (NASDAQ: DRWI) soared 32.08% to $2.10 in the pre-market trading after the company reported that it has been selected as a microwave solutions provider for backhaul connectivity by Gogo (NASDAQ: GOGO).

• [By Bryan Murphy]

  I hate to be the one to day I told you so, but, I told you so. Back on January 3rd I suggested DragonWave, Inc. (NASDAQ:DRWI) was on the verge of a rally, and only needed to clear one more hurdle to get the ball rolling to the point where it wouldn't stop. Well, DRWI did the deed two trading days later, and sure enough the stock's advanced 6% since then (and was up as much as 16% at one point earlier today).� Better still, it looks like the bulls have only begun to do their thing.